Study reveals heart failure insights at single-cell level

Researchers examined the cell-intrinsic effects of hematopoietic stem cells with somatic mutations in circulating cells from heart failure patients.

Debiopharm, ITM ink €300M licensing deal for cancer treatment

Debiopharm and ITM announced a licensing deal for a radiopharmaceutical treatment that’s being investigated in several cancers. Debiopharm, which is based in Switzerland, is eligible

September 13, 2024

Data Insights – Pharmaceutical Technology

By Company Name No Filter Selected Bristol-Myers Squibb (342) Novartis (237) Merck (187) AstraZeneca (181) Pfizer (177) F. Hoffmann-La Roche (164) AbbVie (148) Eli Lilly

February 16, 2024

‘Search mode’: Human challenge trial company looks to buy small CROs

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

July 18, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.